NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare rigorously for the NAPLEX, the pivotal examination for pharmacy licensure! Gain confidence with expertly crafted quizzes and study materials tailored for aspiring pharmacists. Elevate your understanding and skills today!

Practice this question and more.

What is the primary warning associated with Belatacept?

Increased risk of post-transplant lymphoproliferative disorder
May cause severe liver damage
Risk of severe allergic reactions
May lead to acute renal failure

The correct answer is: Increased risk of post-transplant lymphoproliferative disorder

The primary warning associated with Belatacept is an increased risk of post-transplant lymphoproliferative disorder. Belatacept is an immunosuppressive medication that is used in transplant patients to prevent rejection of the transplanted organ. However, it is important to monitor for signs of post-transplant lymphoproliferative disorder, which is a type of cancer that can develop due to the suppression of the immune system. This risk is greater in patients who have previously been infected with the Epstein-Barr virus. The other options are incorrect because while Belatacept may cause liver damage, severe allergic reactions, and acute renal failure, these are not the primary warning associated with this medication. It is important to discuss any potential risks and side effects with a healthcare provider.